Literature DB >> 10333925

Diabetic ketoacidosis associated with clozapine treatment.

A Colli, M Cocciolo, F Francobandiera, F Rogantin, N Cattalini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10333925     DOI： 10.2337/diacare.22.1.176a

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  11 in total

Review 1.  Atypical antipsychotics and diabetic ketoacidosis: a review.

Authors:  Melanie D Guenette; Margaret Hahn; Tony A Cohn; Celine Teo; Gary J Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

Review 2.  Atypical antipsychotic-induced diabetes mellitus: how strong is the evidence?

Authors:  David C Henderson
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 3.  Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Authors:  John W Newcomer
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 4.  Fatalities associated with therapeutic use and overdose of atypical antipsychotics.

Authors:  Adam Trenton; Glenn Currier; Frank Zwemer
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 5.  Diabetes mellitus and other metabolic disturbances induced by atypical antipsychotic agents.

Authors:  David C Henderson
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

6.  Ziprasidone as an adjuvant for clozapine- or olanzapine-associated medical morbidity in chronic schizophrenia.

Authors:  David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Sharon I Forstbauer; Kate Miley; Ryan Boxill; Oliver Freudenreich; Corrine Cather; Anne E Evins; Donald C Goff
Journal:  Hum Psychopharmacol       Date:  2009-04       Impact factor: 1.672

Review 7.  Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Authors:  Kimberly A Stigler; Marc N Potenza; David J Posey; Christopher J McDougle
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 8.  Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Authors:  Kristina Melkersson; Marja-Liisa Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Treatment of Diabetic Ketoacidosis Associated With Antipsychotic Medication: Literature Review.

Authors:  Antonia Vuk; Maja Baretic; Martina Matovinovic Osvatic; Igor Filipcic; Nikolina Jovanovic; Martina Rojnic Kuzman
Journal:  J Clin Psychopharmacol       Date:  2017-10       Impact factor: 3.153

10.  The metabolic side effects of 12 antipsychotic drugs used for the treatment of schizophrenia on glucose: a network meta-analysis.

Authors:  Yangyu Zhang; Yingyu Liu; Yingying Su; Yueyue You; Yue Ma; Guang Yang; Yan Song; Xinyu Liu; Mohan Wang; Lili Zhang; Changgui Kou
Journal:  BMC Psychiatry       Date:  2017-11-21       Impact factor: 3.630
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.